Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Agenus Inc (AGEN)

Agenus Inc (AGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 265,125
  • Shares Outstanding, K 20,285
  • Annual Sales, $ 156,310 K
  • Annual Income, $ -245,760 K
  • 60-Month Beta 1.25
  • Price/Sales 1.62
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AGEN with:

Options Overview Details

View History
  • Implied Volatility 152.72% ( -5.96%)
  • Historical Volatility 166.25%
  • IV Percentile 69%
  • IV Rank 19.64%
  • IV High 615.22% on 11/17/23
  • IV Low 39.67% on 08/14/23
  • Put/Call Vol Ratio 0.29
  • Today's Volume 728
  • Volume Avg (30-Day) 725
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 71,236
  • Open Int (30-Day) 79,629

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -3.10
  • Number of Estimates 4
  • High Estimate -1.60
  • Low Estimate -4.20
  • Prior Year -4.40
  • Growth Rate Est. (year over year) +29.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.78 +171.20%
on 04/18/24
14.24 -9.06%
on 04/29/24
+2.88 (+28.55%)
since 04/05/24
3-Month
4.78 +171.20%
on 04/18/24
18.98 -31.77%
on 02/14/24
-1.14 (-8.06%)
since 02/06/24
52-Week
4.78 +171.20%
on 04/18/24
42.60 -69.60%
on 06/09/23
-18.45 (-58.76%)
since 05/05/23

Most Recent Stories

More News
Up 40%: Is This Red-Hot Growth Stock Still a Buy?

This small-cap biotech stock is surging. Time to buy?

AGEN : 12.95 (-0.92%)
Down 75%. Is Agenus Stock a Buy on the Dip?

Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.

RILY : 30.02 (-3.47%)
MRK : 127.57 (+0.05%)
BMY : 43.90 (-0.20%)
GSK : 43.45 (-0.11%)
AGEN : 12.95 (-0.92%)
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?

These stocks could rocket higher, but they also present significant risks.

BMY : 43.90 (-0.20%)
GSK : 43.45 (-0.11%)
RILY : 30.02 (-3.47%)
DNA : 0.9881 (+3.47%)
AGEN : 12.95 (-0.92%)
Agenus (AGEN) Q4 2023 Earnings Call Transcript

AGEN earnings call for the period ending December 31, 2023.

AGEN : 12.95 (-0.92%)
Agenus: Q4 Earnings Snapshot

Agenus: Q4 Earnings Snapshot

AGEN : 12.95 (-0.92%)
Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today

The company hopes to engineer a 1-for-20 reverse stock split.

NDAQ : 61.60 (+1.20%)
AGEN : 12.95 (-0.92%)
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street

These two biotech stocks could be poised for a trend reversal.

BMY : 43.90 (-0.20%)
AGEN : 12.95 (-0.92%)
CHRS : 2.22 (-2.20%)
Agenus: Q3 Earnings Snapshot

Agenus: Q3 Earnings Snapshot

AGEN : 12.95 (-0.92%)
3 Magnificent Growth Stocks to Buy on the Dip

These three biotech stocks are attractive buys right now.

AGEN : 12.95 (-0.92%)
BCRX : 5.27 (+18.43%)
NNOX : 9.45 (+1.12%)
Betting Big On Biotech: Six Undervalued Biotech Stocks To Keep On Your Radar

Following a tumultuous performance year, the biotechnology sector is steadily regaining traction once again, with investors starting to reveal a somewhat bullish sentiment despite having to endure macroeconomic...

HALO : 40.86 (+2.38%)
KNSA : 19.99 (-0.45%)
ACAD : 17.00 (-0.29%)
HRMY : 30.90 (-2.12%)
AMPH : 42.68 (+0.52%)
INCY : 54.08 (+0.60%)
AGEN : 12.95 (-0.92%)
NVS : 97.73 (+0.47%)
PFE : 28.16 (+1.26%)
SGEN : 228.74 (-0.07%)
MRK : 127.57 (+0.05%)
RXDX : 199.92 (+0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's...

See More

Key Turning Points

3rd Resistance Point 14.02
2nd Resistance Point 13.70
1st Resistance Point 13.33
Last Price 12.95
1st Support Level 12.64
2nd Support Level 12.32
3rd Support Level 11.95

See More

52-Week High 42.60
Fibonacci 61.8% 28.15
Fibonacci 50% 23.69
Fibonacci 38.2% 19.22
Last Price 12.95
52-Week Low 4.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar